The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $218.85

Today's change0.00 0.00%
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $218.85

Today's change0.00 0.00%
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.

Allergan plc closed at (U.S.)$218.85.

Over the last five days, shares have lost 3.80% and sit 2.91% above their 52-week low. This security has underperformed the S&P 500 by 22.19% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $218.85
  • High--
  • Low--
  • Bid / Ask(U.S.) $215.20 / (U.S.) $228.75
  • YTD % change-29.97%
  • Volume0
  • Average volume (10-day)3,959,326
  • Average volume (1-month)6,698,855
  • Average volume (3-month)4,007,654
  • 52-week range(U.S.) $212.67 to (U.S.) $340.34
  • Beta0.60
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward15.44×
  • Forward PEG1.50×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$8.04
Updated April 28 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.01%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue4,1984,0895,7554,234
Total other revenue--------
Total revenue4,1984,0895,7554,234
Gross profit3,0872,8463,6252,521
Total cost of revenue1,1111,2432,1301,713
Total operating expense4,7385,4325,9704,556
Selling / general / administrative1,3271,0731,4611,429
Research & development4451,561653431
Depreciation / amortization1,5871,5601,674925
Interest expense (income), net operating--------
Unusual expense (income)269-45358
Other operating expenses, total--------
Operating income-540-1,344-215-322
Interest income (expense), net non-operating-341-340-340-172
Gain (loss) on sale of assets--5----
Other--------
Income before tax-874-1,680-549-690
Income after tax-769-855-242-512
Income tax, total-105-825-307-178
Net income-6315,301-243-512
Total adjustments to net income-70-70-70-23
Net income before extra. items-771-856-243-512
Minority interest-2-1-20
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-840-926-313-535
Inc. avail. to common incl. extra. items-7015,232-313-535
Diluted net income-7015,232-313-535
Dilution adjustment--0--0
Diluted weighted average shares395394393290
Diluted EPS excluding extraordinary itemsvalue per share-2.13-2.35-0.80-1.85
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-1.69-2.37-0.71-1.72